D
Verastem, Inc. VSTM
$7.50 $0.000.00% NASDAQ
Recommendation
Prev Close
$7.50
Volume
1,805,120
Avg Vol (90D)
1,211,344
Market Cap
$386.17M
Dividend & Yield
--
52-Week Range
$2.10 - $13.52
P/E (TTM)
--
EPS (TTM)
-$3.50
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Verastem Oncology Announces $75 million Private Placement
4/25/2025 - GuruFocus
Verastem Oncology Announces $75 million Private Placement VSTM Stock News
4/25/2025 - GuruFocus
Verastem Oncology Announces $75 million Private Placement
4/25/2025 - Business Wire
Verastem (VSTM, $7.12) RSI Indicator left the overbought zone on April 23, 2025
4/24/2025 - Tickeron - Technical Analysis
Verastem (VSTM) Gains FDA Nod for Novel Cancer Drug VS-7375
4/23/2025 - GuruFocus
Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, ...
4/23/2025 - GuruFocus
Verastem Oncology to initiate trial for its targeted cancer therapy
4/23/2025 - Seeking Alpha - Healthcare
Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, ...
4/23/2025 - GuruFocus
Verastem (VSTM) Advances VS-7375 for Cancer Treatment with FDA Approval VSTM Stock News
4/23/2025 - GuruFocus
Verastem announces U.S. IND clearance of VS-7375
4/23/2025 - TipRanks Financial Blog
Verastem announces U.S. IND clearance of VS-7375
4/23/2025 - The Fly
Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
4/23/2025 - Business Wire
Verastem (VSTM, $7.04) price may drop as it broke higher Bollinger Band on Apr 22, 2025
4/23/2025 - Tickeron - Stocks
Verastem (VSTM, $7.04) Aroon Indicator entered a Downtrend on April 22, 2025.
4/23/2025 - Tickeron - Stocks
Verastem Oncology to Report Q1 Earnings: What's in the Cards?
4/22/2025 - Zacks Investment Research
Verastem (VSTM, $6.21) Aroon Indicator entered a Downtrend on April 21, 2025.
4/22/2025 - Tickeron - Technical Analysis
Verastem (VSTM, $6.21) price moved above its 50-day Moving Average on April 21, 2025
4/22/2025 - Tickeron - Technical Analysis
Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Recommendation of "Buy" from Brokerages
4/21/2025 - Ticker Report
Verastem (NASDAQ:VSTM) Rating Lowered to Sell at StockNews.com
4/21/2025 - MarketBeat
Verastem (NASDAQ:VSTM) Downgraded to "Sell" Rating by StockNews.com
4/19/2025 - Ticker Report
Verastem (VSTM, $5.74) Aroon Indicator entered a Downtrend on April 17, 2025.
4/18/2025 - Tickeron - Technical Analysis
Verastem, Inc. (NASDAQ:VSTM) Position Trimmed by Kennedy Capital Management LLC
4/18/2025 - MarketBeat
Verastem (VSTM, $4.96) Aroon Indicator entered a Downtrend on April 16, 2025.
4/17/2025 - Tickeron - Stocks
Top Cancer Stocks to Buy to Boost Your Portfolio's Health
4/16/2025 - Zacks Investment Research
Verastem (VSTM, $4.81) Aroon Indicator entered a Downtrend on April 15, 2025.
4/16/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$10.00M
EBITDA (TTM)
-$114.93M
EBIT (TTM)
-$114.96M
Net Income (TTM)
-$130.64M
Balance Sheet
Total Assets (Q)
$101.54M
Total Debt (Q)
$42.25M
Total Liabilities (Q)
$130.43M
Book Value Per Share (Q)
-$0.6452
Cash Flow
Cash from Operations (TTM)
-$104.77M
Cash from Investing (TTM)
$59.97M
Cash from Financing (TTM)
$54.78M
Net Change in Cash (TTM)
$9.98M
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.58
7-Day Total Return
55.93%
30-Day Total Return
4.02%
60-Day Total Return
24.38%
90-Day Total Return
66.67%
Year to Date Total Return
15.56%
1-Year Total Return
-18.61%
2-Year Total Return
68.37%
3-Year Total Return
-60.44%
5-Year Total Return
-70.31%
52-week Low
Aug 05, 2024 - $2.10
52-week High
May 15, 2024 - $13.52
Valuation
Market Cap
$386.17M - Small Cap
Enterprise Value
$339.61M
Price/Sales (TTM)
36.53
Price/Book (Q)
-11.62
Dividends and Shares
Shares Outstanding
48.71M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.verastem.com
Phone Number
781 292 4200
Address
117 Kendrick Street
Needham, MA 02494
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed